Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2021

Sep 1, 2021

29841_dirs_2021-09-01_9a87fa4b-992e-45e7-bbf2-9f4912c10d12.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-08-31

Reporting Person: Lerman Bradley E (SVP General Counsel & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-31 Ordinary Shares M 50775 $74.84 Acquired 99538 Direct
2021-08-31 Ordinary Shares S 50775 $134.17 Disposed 48763 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-31 Stock Option (Right to Buy) $74.84 M 50775 Disposed 2025-01-27 Ordinary Shares (50775) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.

F3: This date was previously reported incorrectly as 7/28/2024.